Brian Michael Boni, M.D. Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 1100 Trancas St, Suite 300, Napa, CA 94558 Phone: 707-257-4084 |
Norman Franklin Seidenverg, M.D. Preventive Medicine - Aerospace Medicine Medicare: Not Enrolled in Medicare Practice Location: 2030 Airport Rd, Napa, CA 94558 Phone: 707-253-8050 |
Dr. Claude Lee Newman, M.D. Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 477 Devlin Rd, Suite 109, Napa, CA 94558 Phone: 707-253-8084 Fax: 707-254-0195 |
Kenneth R. Wilkes, MD Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 3285 Claremont Way, Napa, CA 94558 Phone: 707-258-2500 |
Dr. Abhijit A Adhye, M.D. Medicare: Accepting Medicare Assignments Practice Location: 1100 Trancas St Ste 201, Napa, CA 94558 Phone: 707-251-1867 Fax: 707-257-4116 |
News Archive
Biophysicists have discovered why the bacteria that cause tuberculosis (TB) are naturally somewhat resistant to antibiotics known as fluoroquinolones. Their findings, based on mapping the detailed three-dimensional structure of the drugs interacting with an essential enzyme in the TB germ, also reveal why some TB drugs are more potent than others and suggest how drug developers can make fluoroquinolones more efficacious against mutations that make the lung disease drug resistant.
Following a dramatic, last-minute Democratic filibuster late last week, Texas House lawmakers in a special session Tuesday tentatively approved controversial abortion restrictions after more contentious debate.
vielife has received certification for the fifth consecutive year from the U.S.-based National Committee for Quality Assurance (NCQA) in the categories of Health Appraisals and Self Management Tools.
SFJ Pharma Ltd. II announced today that it has entered into a collaborative development agreement with Pfizer Inc. to conduct a Phase 3 clinical trial in Asia of Pfizer's investigational agent axitinib for the adjuvant treatment of patients at high risk of recurrent renal cell carcinoma (RCC) following nephrectomy.
› Verified 6 days ago